Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Denschlag, D; Ackermann, S; Battista, MJ; Cremer, W; Egerer, G; Follmann, M; Haas, H; Harter, P; Hettmer, S; Horn, LC; Juhasz-Boess, I; Kast, K; Köhler, G; Kröncke, T; Lindel, K; Mallmann, P; Meyer-Steinacker, R; Mustea, A; Petru, E; Reichardt, P; Schmidt, D; Strauss, HG; Tempfer, C; Thiel, F; Ulrich, U; Vogl, T; Vordermark, D; Gass, P; Beckmann, MW.
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019).
Geburtshilfe Frauenheilkd. 2019; 79(10):1043-1060
Doi: 10.1055/a-0882-4116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Petru Edgar
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Aims This is an official guideline published and coordinated by the German Society of Gynecology and Obstetrics (DGGG) and the Austrian Society of Gynecology and Obstetrics (OEGGG). Because of their rarity and heterogeneous histopathology, uterine sarcomas are challenging in terms of how they should be managed clinically, and treatment requires a multidisciplinary approach. To our knowledge, there are currently no binding evidence-based recommendations for the appropriate management of this heterogeneous group of tumors. Methods This S2k guideline was first published in 2015. The update published here is the result of the consensus of a representative interdisciplinary group of experts who carried out a systematic search of the literature on uterine sarcomas in the context of the guidelines program of the DGGG, OEGGG and SGGG. Members of the participating professional societies achieved a formal consensus after a moderated structured consensus process. Recommendations The consensus-based recommendations and statements include the epidemiology, classification, staging, symptoms, general diagnostic work-up and general pathology of uterine sarcomas as well as the genetic predisposition to develop uterine sarcomas. Also included are statements on the management of leiomyosarcomas, (low and high-grade) endometrial stromal sarcomas and undifferentiated uterine sarcomas and adenosarcomas. Finally, the guideline considers the follow-up and morcellation of uterine sarcomas and the information provided to patients. © Thieme Medical Publishers.
- Find related publications in this database (Keywords)
- uterine sarcoma
- leiomyosarcoma
- endometrial stromal sarcoma
- adenosarcoma
- morcellation